Copyright Reports & Markets. All rights reserved.

In-Silico Drug Discovery-Global Market Status and Trend Report 2016-2026

Request for Sample of this report
Buy now

Table of Contents

    Chapter 1 Overview of In-Silico Drug Discovery

    • 1.1 Definition of In-Silico Drug Discovery in This Report
    • 1.2 Commercial Types of In-Silico Drug Discovery
      • 1.2.1 Software as a Service (Cloud)
      • 1.2.2 Consultancy as a Service
      • 1.2.3 Software
    • 1.3 Downstream Application of In-Silico Drug Discovery
      • 1.3.1 Contract Research Organization
      • 1.3.2 Pharmaceutical Industry
      • 1.3.3 Academic and Research Institutes
      • 1.3.4 Others
    • 1.4 Development History of In-Silico Drug Discovery
    • 1.5 Market Status and Trend of In-Silico Drug Discovery 2016-2026
      • 1.5.1 Global In-Silico Drug Discovery Market Status and Trend 2016-2026
      • 1.5.2 Regional In-Silico Drug Discovery Market Status and Trend 2016-2026

    Chapter 2 Global Market Status and Forecast by Regions

    • 2.1 Market Development of In-Silico Drug Discovery 2016-2021
    • 2.2 Production Market of In-Silico Drug Discovery by Regions
      • 2.2.1 Production Volume of In-Silico Drug Discovery by Regions
      • 2.2.2 Production Value of In-Silico Drug Discovery by Regions
    • 2.3 Demand Market of In-Silico Drug Discovery by Regions
    • 2.4 Production and Demand Status of In-Silico Drug Discovery by Regions
      • 2.4.1 Production and Demand Status of In-Silico Drug Discovery by Regions 2016-2021
      • 2.4.2 Import and Export Status of In-Silico Drug Discovery by Regions 2016-2021

    Chapter 3 Global Market Status and Forecast by Types

    • 3.1 Production Volume of In-Silico Drug Discovery by Types
    • 3.2 Production Value of In-Silico Drug Discovery by Types
    • 3.3 Market Forecast of In-Silico Drug Discovery by Types

    Chapter 4 Global Market Status and Forecast by Downstream Industry

    • 4.1 Demand Volume of In-Silico Drug Discovery by Downstream Industry
    • 4.2 Market Forecast of In-Silico Drug Discovery by Downstream Industry

    Chapter 5 Market Driving Factor Analysis of In-Silico Drug Discovery

    • 5.1 Global Economy Situation and Trend Overview
    • 5.2 In-Silico Drug Discovery Downstream Industry Situation and Trend Overview

    Chapter 6 In-Silico Drug Discovery Market Competition Status by Major Manufacturers

    • 6.1 Production Volume of In-Silico Drug Discovery by Major Manufacturers
    • 6.2 Production Value of In-Silico Drug Discovery by Major Manufacturers
    • 6.3 Basic Information of In-Silico Drug Discovery by Major Manufacturers
      • 6.3.1 Headquarters Location and Established Time of In-Silico Drug Discovery Major Manufacturer
      • 6.3.2 Employees and Revenue Level of In-Silico Drug Discovery Major Manufacturer
    • 6.4 Market Competition News and Trend
      • 6.4.1 Merger, Consolidation or Acquisition News
      • 6.4.2 Investment or Disinvestment News
      • 6.4.3 New Product Development and Launch

    Chapter 7 In-Silico Drug Discovery Major Manufacturers Introduction and Market Data

    • 7.1 Charles River
      • 7.1.1 Company profile
      • 7.1.2 Representative In-Silico Drug Discovery Product
      • 7.1.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of Charles River
    • 7.2 Certara USA, Inc.
      • 7.2.1 Company profile
      • 7.2.2 Representative In-Silico Drug Discovery Product
      • 7.2.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of Certara USA, Inc.
    • 7.3 Evotec
      • 7.3.1 Company profile
      • 7.3.2 Representative In-Silico Drug Discovery Product
      • 7.3.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of Evotec
    • 7.4 Dassault System (Biovia)
      • 7.4.1 Company profile
      • 7.4.2 Representative In-Silico Drug Discovery Product
      • 7.4.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of Dassault System (Biovia)
    • 7.5 Albany Molecular Research Inc. (AMRI)
      • 7.5.1 Company profile
      • 7.5.2 Representative In-Silico Drug Discovery Product
      • 7.5.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of Albany Molecular Research Inc. (AMRI)
    • 7.6 Selvita
      • 7.6.1 Company profile
      • 7.6.2 Representative In-Silico Drug Discovery Product
      • 7.6.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of Selvita
    • 7.7 Schrödinger, Inc.
      • 7.7.1 Company profile
      • 7.7.2 Representative In-Silico Drug Discovery Product
      • 7.7.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of Schrödinger, Inc.
    • 7.8 GVK BIO
      • 7.8.1 Company profile
      • 7.8.2 Representative In-Silico Drug Discovery Product
      • 7.8.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of GVK BIO
    • 7.9 OpenEye Scientific Software
      • 7.9.1 Company profile
      • 7.9.2 Representative In-Silico Drug Discovery Product
      • 7.9.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of OpenEye Scientific Software
    • 7.10 Chemical Computing Group (CCG)
      • 7.10.1 Company profile
      • 7.10.2 Representative In-Silico Drug Discovery Product
      • 7.10.3 In-Silico Drug Discovery Sales, Revenue, Price and Gross Margin of Chemical Computing Group (CCG)

    Chapter 8 Upstream and Downstream Market Analysis of In-Silico Drug Discovery

    • 8.1 Industry Chain of In-Silico Drug Discovery
    • 8.2 Upstream Market and Representative Companies Analysis
    • 8.3 Downstream Market and Representative Companies Analysis

    Chapter 9 Cost and Gross Margin Analysis of In-Silico Drug Discovery

    • 9.1 Cost Structure Analysis of In-Silico Drug Discovery
    • 9.2 Raw Materials Cost Analysis of In-Silico Drug Discovery
    • 9.3 Labor Cost Analysis of In-Silico Drug Discovery
    • 9.4 Manufacturing Expenses Analysis of In-Silico Drug Discovery

    Chapter 10 Marketing Status Analysis of In-Silico Drug Discovery

    • 10.1 Marketing Channel
      • 10.1.1 Direct Marketing
      • 10.1.2 Indirect Marketing
      • 10.1.3 Marketing Channel Development Trend
    • 10.2 Market Positioning
      • 10.2.1 Pricing Strategy
      • 10.2.2 Brand Strategy
      • 10.2.3 Target Client
    • 10.3 Distributors/Traders List

    Chapter 11 Report Conclusion

      Chapter 12 Research Methodology and Reference

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources

      Report Summary

      In-Silico Drug Discovery-Global Market Status and Trend Report 2016-2026 offers a comprehensive analysis on In-Silico Drug Discovery industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

      Worldwide and Regional Market Size of In-Silico Drug Discovery 2016-2021, and development forecast 2022-2026
      Main manufacturers/suppliers of In-Silico Drug Discovery worldwide, with company and product introduction, position in the In-Silico Drug Discovery market
      Market status and development trend of In-Silico Drug Discovery by types and applications
      Cost and profit status of In-Silico Drug Discovery, and marketing status
      Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium In-Silico Drug Discovery market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the In-Silico Drug Discovery industry.

      The report segments the global In-Silico Drug Discovery market as:

      Global In-Silico Drug Discovery Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
      North America
      Europe
      China
      Japan
      Rest APAC
      Latin America

      Global In-Silico Drug Discovery Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
      Software as a Service (Cloud)
      Consultancy as a Service
      Software

      Global In-Silico Drug Discovery Market: Application Segment Analysis (Consumption Volume and Market Share 2016-2026; Downstream Customers and Market Analysis)
      Contract Research Organization
      Pharmaceutical Industry
      Academic and Research Institutes
      Others

      Global In-Silico Drug Discovery Market: Manufacturers Segment Analysis (Company and Product introduction, In-Silico Drug Discovery Sales Volume, Revenue, Price and Gross Margin):
      Charles River
      Certara USA, Inc.
      Evotec
      Dassault System (Biovia)
      Albany Molecular Research Inc. (AMRI)
      Selvita
      Schrödinger, Inc.
      GVK BIO
      OpenEye Scientific Software
      Chemical Computing Group (CCG)

      In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
      Buy now